Glenmark's anti-diabetic drug biosimilar claims to cut therapy cost by 70%
The drug is being marketed under the brand name ‘Lirafit’, following approval from the Drug Controller General of India.
glenmark pharmaceuticals
January 2024
September 2023
December 2022
January 2020
Glenmark sells bulk drug business to Nirma for ₹5,651 cr
GLS is a leading developer and manufacturer of active pharmaceutical ingredients, while FMCG major Nirma makes products from cosmetics to soaps to detergents
Glenmark Pharma surges 6% on launching type 2 diabetes drug
Glenmark has launched Zita‐PioMet, India’s first triple fixed-dose combination for high insulin‐resistant type 2 diabetes.
Winners and losers of the decade
More than 56% of the 1,942 listed companies in India generated a positive CAGR between 2010 and 2019.
